Addressing Complacency, Convenience and Confidence

Similar documents
The State of Measles and Rubella in the WHO European Region

Immunization in the context of adolescent health

The challenge of vaccine hesitancy in the European Union

Measles and rubella monitoring January 2015

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

ECDC s role in the fight against HIV/AIDS in Europe

Progress in maternal and child health: Uzbekistan and WHO European Region

How to present the European Vaccine Action Plan (EVAP)

Vaccine Acceptance, Hesitancy and Refusal

Alcohol-related harm in Europe and the WHO policy response

3. CONCLUSIONS AND RECOMMENDATIONS

How do we sustain acceptance in societies with mandates: The situation in Germany

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

Monthly measles and rubella monitoring report

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

European monthly measles monitoring (EMMO)

Recommendations for vaccination

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

Critical immunity thresholds for measles elimination

SEVENTH MEETING OF THE EUROPEAN REGIONAL VERIFICATION COMMISSION FOR MEASLES AND RUBELLA ELIMINATION (RVC) June 2018 Paris, France

The Smokefree Class Competition What is it about?

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe

Çeşme Izmir, Turkey, September 2013

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Update on Progress and Challenges in Achieving Measles and Rubella Targets

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Poliomyelitis eradication in the WHO European Region

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Highlighting in the WHO European Region:

EUVAC.NET A surveillance network for vaccine-preventable diseases

Vaccine hesitancy in the EU: state of play and impact on vaccination programmes

European status report on alcohol and health Leadership, awareness and commitment

African swine fever in the EU 13/10/16 EP

MEASLES AND RUBELLA ELIMINATION 2015 PACKAGE FOR ACCELERATED ACTION:

Current issues with variability in vaccine uptake and what can be done to improve it

Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

WHO position paper on rubella vaccines

GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL

World Immunization Week 2013

Ending Malaria in Nigeria: The WHO Agenda

Consultation on Strengthened EU cooperation against vaccine preventable diseases

COMMISSION OF THE EUROPEAN COMMUNITIES

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10%

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Lessons Learned from SIAs:

Impact and effectiveness of national immunisation programmes. David Green, Nurse Consultant, Immunisations Public Health England

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN

SURVEILLANCE REPORT. Measles and rubella surveillance

Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges

HPV, Cancer and the Vaccination Programme

Safety Requirements for Long Term Operation or Ageing Aspects and for Design, Construction and Operation of New Nuclear Power Plants

Gavi Alliance Strategy : Goal level indicators and disease dashboard

MedInform. Ethical and healthcare considerations in relation to mandatory vaccination - Bulgarian perspective. Literature Review

SUCCESSFULLY TRANSITIONING NIGERIA FROM GAVI SUPPORT

Prince Albert Parkland Regional Health Authority Immunization coverage

Measles and Rubella Global Update SAGE 19 October 2017

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Action plan for the health sector response to viral hepatitis in the WHO European Region

Expanded Programme on Immunization

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HUMANITARIAN AID - ECHO. Emergency Humanitarian Aid Decision

Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC)

MEASLES VACCINATION IN EUROPEAN UNION

Deliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society

Where we stand in EFORT

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

Global dengue situation and strategy for prevention and control ALERT AND RESPONSE OPERATIONS

Key issues for HIV testing and

Technical Guidance Note for Global Fund HIV Proposals

Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Disparities in influenza vaccination coverage rates in health care workers and the ways to overcome the barriers

Fifth report of Committee A

Changing the prevention paradigm for the future what Europe can do

The challenge of obesity in the WHO European Region

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Highlight underserved groups for screening, prevention and treatment of viral hepatitis B and C in Europe LJUBLJANA, SLOVENIA March 2016

Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts

Updates from the European Centre for Disease Prevention and Control

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Key Highlights continued

CLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI. Geoffrey Zimkambani Chirwa EPI Manager

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment)

Understanding vaccine hesitancy in a post-factual era

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States

Outline of the presentation

Third meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) November 2014 Copenhagen, Denmark

New trends in harm reduction in Europe: progress made challenges ahead

Transcription:

Combating vaccine-preventable diseases in the European Region: focus on Measles Elimination Addressing Complacency, Convenience and Confidence Robb Butler VPI/DCE WHO Regional Office for Europe

WHO European Region 53 Member States 890 million persons

Video File

Countries with highest number of measles cases in the WHO European Region, 2009-2012 Country 2009 2010 2011 2012 Total Bulgaria 2249 22006 157 0 24412 France 1541 5019 15214 745 22519 Ukraine 24 42 1313 11086 12465 Romania 8 187 4417 2447 7059 Italy 173 861 5179 530 6743 Spain 43 285 3507 401 4236 United Kingdom 1176 397 1083 1093 3749 Germany 572 805 1600 139 3116 Russian Federation 101 152 783 1771 2807 Switzerland 999 81 644 58 1782 Total 6886 29835 33897 18270 88888 % of all in WHO 92.82 96.71 89.45 96.85 93.54 WHO Euroepan Region 7419 30850 37893 18865 95027 Ten countries reported almost 95% of all cases in the Region Member States with nationwide outbreaks or endemic measles 4

Proportion of measles cases by age groups, WHO European Region 2009-2012 50.0 40.0 54.5% 30.0 20.0 10.0 10.5% 20.3% 14.7% 12.9% 14.6% 16.2% 10.8% 0.0 <1 "1-4" "5-9" "10-14" "15-19" "20-29" " 30" Adolescents and young adults around 50% of cases 5

What do we need to do to attain measles elimination in Europe? (1) 1. Continued efforts to address barriers for vaccine uptake Steady commitment (secure funding for vaccine purchase and distribution, advocacy) Opportunities for discussing vaccination with HC staff Reminders and recall systems (as part of implementation of immunization programme) Equip with tools to better identify barriers, plan and tailor immunization programmes to reach the underserved.

What do we need to do to attain measles elimination in Europe? (2) 2. To focus on susceptible populations (under-vaccinated) Provide additional vaccination opportunity, including SIA, to all high risk groups and susceptibles (2000-2010, 57 mill) Better profiling : understanding attitudes, beliefs, and social and behavioural determinants Better communication strategies Exploration of non-traditional service delivery Improve integration with health-care systems (registration, eligibility, as well as outreach programmes, mediators)

What do we need to do to attain measles elimination in Europe? (3) 3. Enhance surveillance and immunization monitoring Rapid investigation of suspected cases with laboratory tests Seroprevalence studies (free testing for adults) More accurate monitoring of immunization coverage (to include all population)

What do we need to do to attain measles elimination in Europe? (4) 4. Policies to improve prevention and control Hospitals and health-care settings (strengthen recommendation Finland: compulsory vaccination for HCWs) School entry requirement (as in some states of the US) Pre-travel vaccination (liase with travel agencies and travel health centres) Immunise baby-immunise parents policy Standing orders and pre-discharge patient handouts WHO international travel and health guidelines

What do we need to do to attain measles elimination in Europe? (5) 5. Improve availability of high-quality information Via government and non-government websites Medical and nursing curricula Media and communication profiling: conduct media audits and exposure studies and accordingly draw upon: Social media Traditional mass media Tried and tested interpersonal communication techniques

Verification process for elimination Draft Framework finalized in 2011 Regional Verification Commission established in January 2012 Establishing of National Verification Commissions ongoing Developing guidelines for documenting verification - epidemiologic evidence of interruption of transmission Action plans for each Member State http://www.euro.who.int/en/what-we-do/health-topics/communicable-diseases/measles-and-rubella/publications/2012/eliminating-measles-and-rubellaframework-fonr-the-verification-process-in-the-who-european-region

2.2 Better profiling : understanding attitudes, beliefs, and social and behavioural determinants 5.3 Media and communication profiling: conducting media audits and exposure studies Complacency, Convenience and Confidence tackling the three Cs

Caregiver Behaviours The Determinants Caregiver Behaviours: The Determinants

Confident enough to make the right decision?

Just how Convenient is immunization?

Final Messages Its not the parent and caregiver who should bare the full responsibility and weight of our expectations Better profiling of susceptible populations and tailoring of responses is necessary Need to ramp up political advocacy and commitment